Pharmacology 1983-01-01

The pharmacology of verapamil. V. Tissue distribution of verapamil and norverapamil in rat and dog.

S R Hamann, G D Todd, R G McAllister

Index: Pharmacology 27 , 1-8, (1983)

Full Text: HTML

Abstract

The relative distribution of verapamil and its demethylated metabolite, norverapamil, was studied in rats at intervals after intraperitoneal injection of the parent drug (30 mg/kg). This route of drug administration simulated oral drug dosing, and the highest concentrations of both unchanged drug and metabolite were found in the liver, with lung and kidney containing most of the remainder. The rates of disappearance of verapamil from various organs followed first-order kinetics, and the most rapid elimination occurred from brain and liver. In contrast, verapamil was given intravenously to 3 dogs by a bolus-infusion method to produce sustained steady state plasma concentrations (80, 140, 250 ng/ml) for 1, 2, and 3 h. After systemic administration, the lungs contained almost half the tissue verapamil and, 20% was found in kidney, with the liver accounting for only 17%. Norverapamil was not found in plasma or brain. These studies contrast the pattern of tissue distribution of verapamil after different routes of drug administration. The variable rates of drug elimination from specific tissues may explain the differing durations of the drug's observed effects.


Related Compounds

  • Norverapamil hydro...

Related Articles:

Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs.

2014-08-01

[J. Infect. Dis. 210(3) , 456-66, (2014)]

Application of permeability-limited physiologically-based pharmacokinetic models: part II - prediction of P-glycoprotein mediated drug-drug interactions with digoxin.

2013-09-01

[J. Pharm. Sci. 102(9) , 3161-73, (2013)]

Stereoselective CZE method for analysis of verapamil and norverapamil in human plasma.

2013-01-01

[Acta Pol. Pharm. 70(3) , 395-401, (2013)]

Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog.

1978-04-01

[Cardiovasc. Res. 12 , 247-254, (1978)]

Physiological pharmacokinetics and pharmacodynamics of (+/-)-verapamil in female rats.

1987-01-01

[Biopharm. Drug Dispos. 8 , 285, (1987)]

More Articles...